Patient-Centered Drug Development - A Roadmap for Pharmaceutical Leaders
Published: August 2015 by eyeforpharma
Putting patients at the center of clinical trials makes the development process radically more effective. Learn about patient inclusion for trial protocol design, innovations in online, social, and mobile, and how they are reshaping clinical trial enterprise & learn about regulation and compliance issues for patient engagement from Eli Lilly, Pfizer, GSK, EPATI, Merck, UCB, US National Health Council, & more.
Learn more »